EP Patent

EP4620519A2 — Methods and compositions relating to chondrisomes from blood products

Assigned to Boston Childrens Hospital · Expires 2025-09-24 · 1y expired

What this patent protects

Therapeutic chondrisome and mitoplast compositions and related methods are described.

USPTO Abstract

Therapeutic chondrisome and mitoplast compositions and related methods are described.

Drugs covered by this patent

Onpattro (PATISIRAN SODIUM) · Alnylam Pharmaceuticals

Patent Metadata

Patent number: EP4620519A2
Jurisdiction: EP
Classification: —
Expires: 2025-09-24
Drug substance claim: No
Drug product claim: No
Assignee: Boston Childrens Hospital
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.